| Application no. and date | 08771562.9 (espacenet) (Federated) (European Patent Register), 20080620 | | Patent/reg. no. and date | DK/EP 2170292, 20140108 | | Publication date | 20100407 | | Priority no. and date | US 945701 P, 20070622 | | EP pub. no. and date |
EP 2170292 20100407 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | 13108-5 | | Inventor | KOO, Otilia, May, Yue, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
NIKFAR, Faranak, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
DIAZ, Steven, 1007 Laurel Trail
Martinsville, New Jersey 08836, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/551 (2006.01) , A61K 45/06 (2006.01) , A61K 9/20 (2006.01) , C07D 213/42 (2006.01) | | Title | Atazanavirholdige sammensætninger i tabletform | | Int. application no. | US2008067622 | | Int. publication no. | WO2009002821 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
